Michael Craig Pine, Chief Corporate Dev.&Strat. Officer at EyePoint Pharmaceuticals, Inc. (EYPT), bought 1,000 shares at $12.21 ($12K) on 2022-03-14, disclosed to the SEC on 2022-03-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.